Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 10/2014

01-10-2014 | Original Article

18F-fluorodeoxyglucose positron emission tomography combined with whole-body computed tomographic angiography in critically ill patients with suspected severe sepsis with no definite diagnosis

Authors: Damien Mandry, Alexis Tatopoulos, Elodie Chevalier-Mathias, Jérémie Lemarié, Pierre-Edouard Bollaert, Véronique Roch, Pierre Olivier, Pierre-Yves Marie, Sébastien Gibot

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 10/2014

Login to get access

Abstract

Purpose

Timely identification of septic foci is critical in patients with severe sepsis or septic shock of unknown origin. This prospective pilot study aimed to assess 18F-fluorodeoxyglucose positron emission tomography (FDG-PET), combined with whole-body computed tomographic angiography (CTA), in patients with suspected severe sepsis and for whom the prior diagnostic workup had been inconclusive.

Methods

Patients hospitalized in an intensive care unit with a suspected severe sepsis but no definite diagnosis after 48 h of extensive investigations were prospectively included and referred for a whole body FDG-PET/CTA. Results from FDG-PET/CTA were assessed according to the final diagnosis obtained after follow-up and additional diagnostic workup.

Results

Seventeen patients were prospectively included, all on mechanical ventilation and 14 under vasopressor drugs. The FDG-PET/CTA exam 1) was responsible for only one desaturation and one hypotension, both quickly reversible under treatment; 2) led to suspect 16 infectious sites among which 13 (81 %) could be confirmed by further diagnostic procedures; and 3) triggered beneficial changes in the medical management of 12 of the 17 study patients (71 %). The FDG-PET/CTA images showed a single or predominant infectious focus in two cases where CTA was negative and in three cases where CTA exhibited multiple possible foci.

Conclusion

Whole-body FDG-PET/CTA appears to be feasible, relatively safe, and provides reliable and useful information, when prospectively planned in patients with suspected severe sepsis and for whom prior diagnostic workup had been inconclusive. The FDG-PET images are particularly helpful when CTA exhibits no or multiple possible sites.
Literature
2.
go back to reference Fu Y, Maianu L, Melbert BR, Garwey MT. Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol Dis. 2004;32:182–90.PubMedCrossRef Fu Y, Maianu L, Melbert BR, Garwey MT. Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol Dis. 2004;32:182–90.PubMedCrossRef
3.
go back to reference Gamelli RL, Liu H, He LK, Hofmann CA. Augmentations of glucose uptake and glucose transporter-1 in macrophages following thermal injury and sepsis in mice. J Leukoc Biol. 1996;59:639–47.PubMed Gamelli RL, Liu H, He LK, Hofmann CA. Augmentations of glucose uptake and glucose transporter-1 in macrophages following thermal injury and sepsis in mice. J Leukoc Biol. 1996;59:639–47.PubMed
4.
go back to reference Gamelli RL, Liu H, He LK, Hofmann CA. Alterations of glucose transporter mRNA and protein levels in brain following thermal injury and sepsis in mice. Shock. 1994;1:395–400.PubMedCrossRef Gamelli RL, Liu H, He LK, Hofmann CA. Alterations of glucose transporter mRNA and protein levels in brain following thermal injury and sepsis in mice. Shock. 1994;1:395–400.PubMedCrossRef
5.
go back to reference Basu S, Chryssikos T, Moghadam-Kia S, Zhuang H, Torigian DA, Alavi A. Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Semin Nucl Med. 2009;39:36–51.PubMedCrossRef Basu S, Chryssikos T, Moghadam-Kia S, Zhuang H, Torigian DA, Alavi A. Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Semin Nucl Med. 2009;39:36–51.PubMedCrossRef
6.
go back to reference Kumar R, Basu S, Torigian D, Anand V, Zhuang H, Alavi A. Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomography. Clin Microbiol Rev. 2008;21:209–24.PubMedCentralPubMedCrossRef Kumar R, Basu S, Torigian D, Anand V, Zhuang H, Alavi A. Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomography. Clin Microbiol Rev. 2008;21:209–24.PubMedCentralPubMedCrossRef
7.
go back to reference Meller J, Sahlmann CO, Scheel AK. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med. 2007;48:35–45.PubMed Meller J, Sahlmann CO, Scheel AK. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med. 2007;48:35–45.PubMed
8.
go back to reference Vos FJ, Bleeker-Rovers CP, Sturm PD, Krabbe PF, van Dijk AP, Cuijpers ML, et al. 18F-FDG PET/CT for detection of metastatic infection in gram-positive bacteremia. J Nucl Med. 2010;51:1234–40.PubMedCrossRef Vos FJ, Bleeker-Rovers CP, Sturm PD, Krabbe PF, van Dijk AP, Cuijpers ML, et al. 18F-FDG PET/CT for detection of metastatic infection in gram-positive bacteremia. J Nucl Med. 2010;51:1234–40.PubMedCrossRef
9.
go back to reference Simons KS, Pickkers P, Bleeker-Rovers CP, Oyen WJ, van der Hoeven JG. F-18-fluorodeoxyglucose positron emission tomography combined with CT in critically ill patients with suspected infection. Intensive Care Med. 2010;36:504–11.PubMedCentralPubMedCrossRef Simons KS, Pickkers P, Bleeker-Rovers CP, Oyen WJ, van der Hoeven JG. F-18-fluorodeoxyglucose positron emission tomography combined with CT in critically ill patients with suspected infection. Intensive Care Med. 2010;36:504–11.PubMedCentralPubMedCrossRef
10.
go back to reference Kluge S, Braune S, Nierhaus A, Wichmann D, Derlin T, Mester J, et al. Diagnostic value of positron emission tomography combined with computed tomography for evaluating patients with septic shock of unknown origin. J Crit Care. 2012;27:316.e1–e7.CrossRef Kluge S, Braune S, Nierhaus A, Wichmann D, Derlin T, Mester J, et al. Diagnostic value of positron emission tomography combined with computed tomography for evaluating patients with septic shock of unknown origin. J Crit Care. 2012;27:316.e1–e7.CrossRef
11.
go back to reference Merrell RC, Latifi R. The abdomen as a source of sepsis in critically ill patient. In: Holzheimer RG, Mannick JA, editors. Surgical treatment: evidence-based and problem-oriented. Munich: Zuckschwerdt; 2001. Merrell RC, Latifi R. The abdomen as a source of sepsis in critically ill patient. In: Holzheimer RG, Mannick JA, editors. Surgical treatment: evidence-based and problem-oriented. Munich: Zuckschwerdt; 2001.
12.
go back to reference Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign guidelines committee including the pediatric subgroup. Intensive Care Med. 2013;39:165–228.PubMedCrossRef Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign guidelines committee including the pediatric subgroup. Intensive Care Med. 2013;39:165–228.PubMedCrossRef
13.
go back to reference Grandpierre S, Desandes E, Meneroux B, Djaballah W, Mandry D, Netter F, et al. Arterial foci of F-18 fluorodesoxyglucose are associated with an enhanced risk of subsequent ischemic stroke in cancer patients: a case–control pilot study. Clin Nucl Med. 2011;36(2):85–90.PubMedCrossRef Grandpierre S, Desandes E, Meneroux B, Djaballah W, Mandry D, Netter F, et al. Arterial foci of F-18 fluorodesoxyglucose are associated with an enhanced risk of subsequent ischemic stroke in cancer patients: a case–control pilot study. Clin Nucl Med. 2011;36(2):85–90.PubMedCrossRef
Metadata
Title
18F-fluorodeoxyglucose positron emission tomography combined with whole-body computed tomographic angiography in critically ill patients with suspected severe sepsis with no definite diagnosis
Authors
Damien Mandry
Alexis Tatopoulos
Elodie Chevalier-Mathias
Jérémie Lemarié
Pierre-Edouard Bollaert
Véronique Roch
Pierre Olivier
Pierre-Yves Marie
Sébastien Gibot
Publication date
01-10-2014
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 10/2014
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-014-2804-9

Other articles of this Issue 10/2014

European Journal of Nuclear Medicine and Molecular Imaging 10/2014 Go to the issue